News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Company, Ltd. (ESALY.PK) and MGI PHARMA, INC. (MOGN) Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA



1/17/2008 8:36:38 AM

TOKYO & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Eisai Co., Ltd. (Tokyo, TSE: 4523) (“Eisai”) and MGI PHARMA, INC. (NASDAQ: MOGN) (“MGI PHARMA”) announced today that the Federal Trade Commission has granted early termination of the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to the acquisition of MGI PHARMA by Eisai.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES